JHS Svendgaard Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

JHS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹14.38

prior close

₹14.35

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-1.7% vs market

Personal Care peers, median of 10sector-1.6%+0.2% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 0.2 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4+0.3-1.7-1.6+0.2

Next day

-6.1+0.7-6.7-1.0-5.0

-5.7+1.0-6.7-1.9-3.8

-10.6+1.1-11.7-1.4-9.3

-6.1+0.8-6.9-1.5-4.6

-6.5+1.3-7.8-0.5-5.9

-7.6+1.7-9.4-1.2-6.5

15d

-8.2+1.5-9.7-3.7-4.5

-6.8+4.0-10.9-2.8-4.1

-13.7+1.8-15.5-0.7-13.0

-29.1-1.0-28.1-0.0-29.0

UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

JHS Svendgaard Laboratories Limited has submitted its audited financial results for the fiscal year ended March 31, 2025 to the NSE. The announcement itself does not include specific revenue, profit, or margin figures. Investors will need to look at the detailed results filing to assess the company's full-year performance. The submission is part of the standard regulatory compliance under listing requirements.

Likely market impact

No immediate price impact can be determined from this announcement alone, as it only confirms the submission of results without disclosing numbers. Shareholders should review the detailed financials for actual performance insights.